Top Markets
#1 Tutorial Tutorial +45.75%
#2 Siacoin Siacoin +28.41%
#3 Official Trump Official Trump +20.74%
#4 Unit Pump Unit Pump +20.47%
#5 Pump.fun Pump.fun +20.47%
#6 Wrapped STX (Velar) Wrapped STX (Velar) +20.32%
#7 EXOD EXOD +18.93%
#8 MowCat MowCat +17.72%
#9 Stacks Stacks +15.29%
#10 Mubarak Mubarak +14.29%
Coin of the day
Tutorial Tutorial
Settings
Language
ENGLISH
Currency
USD
Theme
Energenesis Biomedical CO.,LTD. Energenesis Biomedical CO.,LTD.

Energenesis Biomedical CO.,LTD.

6657
Rank in Stocks #22642
Energenesis Biomedical CO.,LTD., a firm established in 2012 and headquartered... Energenesis Biomedical CO.,LTD., a firm established in 2012 and headquartered in Taipei, Taiwan, is an active participant in the biomedicine sector. The company specializes in the development of a diverse range of medical solutions and research materials. Its primary pharmaceutical pipeline includes ENERGI-F703, which is currently undergoing Phase II clinical trials for the treatment of diabetic foot ulcers, and ENERGI-F701, a topical solution for addressing alopecia that is also in its second phase of clinical assessment. The comprehensive portfolio of therapeutic agents further encompasses: ENERGI-F711, formulated as a cream for burns. ENERGI-F702, designed to combat metabolic diseases. ENERGI-F704, targeting inflammatory bowel disease. ENERGI-F708, for the management of asthma. ENERGI-F705, aimed at controlling Parkinson's disease. ENERGI-F707, addressing mitochondrial deficiencies. ENERGI-F706, used to treat cachexia. ENERGI-F709, which serves as a vaccine adjuvant. ENERGI-F710, intended for the regulation of blood phosphate levels. Beyond its therapeutic developments, Energenesis Biomedical also provides a selection of scientific research products, including reagents for Western blotting, cell culture supplements, components for protein isolation and quantification, various laboratory dyes, and buffer solutions.
Share Price
$0.97305026
Last synced: 2026-08-21
Market Cap
$85.54M
Change (1 day)
1.16%
Change (1 year)
-50.40%
Country
TW
Trade Energenesis Biomedical CO.,LTD. (6657)

Category

Healthcare
Revenue for Energenesis Biomedical CO.,LTD. (6657)
Revenue in Aug 2026 TTM: 0
According to Energenesis Biomedical CO.,LTD. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Energenesis Biomedical CO.,LTD. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH